{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:27:22Z","timestamp":1788449242477,"version":"build-2803163510"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>SARS-CoV-2 remains globally circulating, yet post-pandemic comprehensive molecular, serological, and population-level immunity data from low-resource settings such as Ethiopia are limited. This study employed genomic surveillance with seroepidemiological assessment to characterize the epidemiology of SARS-CoV-2 among individuals presenting with influenza-like illness (ILI) and severe acute respiratory infection (SARI) between May 2023 and April 2024 across 21 influenza sentinel surveillance sites representing diverse regions of Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Respiratory swabs from 8,881 ILI\/SARI patients were tested for SARS-CoV-2 by real-time polymerase chain reaction (RT-PCR). Whole-genome sequencing was performed on samples with cycle threshold (Ct) values \u2264 30 using Oxford Nanopore Technology, and serological testing was performed on blood samples collected from participants aged \u226512 years using the WANTAI enzyme-linked immunosorbent assay (ELISA) targeting the spike receptor-binding domain (RBD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 8,881 participants, the overall SARS-CoV-2 detection rate was 3.3 (95% CI: 2.9\u20133.6). Compared to children under 2 years, older age groups had significantly higher odds of infection: 15\u201349 years (AOR: 1.60; 95% CI: 1.16\u20132.21), 50\u201364 years (AOR: 2.15; 95% CI: 1.31\u20133.54), and \u226565 years (AOR: 2.37; 95% CI: 1.42\u20133.95). ILI cases demonstrated higher positivity than SARI cases (AOR: 2.26; 95% CI: 1.75\u20132.91). SARS-CoV-2 was detected across all seasons, with positivity rates ranging from 1.9% in spring to 6.0% in summer. Whole-genome sequencing of (\n                      <jats:italic>n<\/jats:italic>\n                      = 80) revealed exclusive circulation of Omicron lineages, identifying 19 Omicron sub-lineages, predominantly JN.1.18 (31.3%), JN.1 (8.8%), XBB.1.28 (8.8%), BA.2.86 (7.5%), and XBB.1.34.1 (6.3%). Serological analysis of 690 samples demonstrated 96.8% (95% CI: 95.2\u201398.0%) seropositivity, with no significant demographic variation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates the continued circulation of SARS-CoV-2 in Ethiopia, primarily among adults with influenza-like illness, with distinct seasonal peaks during the summer. The Omicron variant remained dominant, with JN.1 and its descendants prevailing since late 2023 in parallel with a national rise in COVID-19 cases. These findings reinforce that ongoing genomic and syndromic surveillance utilizing established ILI\/SARI platforms remain vital for monitoring viral evolution and guiding targeted public health interventions in low-resource settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1714899","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T07:09:27Z","timestamp":1769411367000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular and seroepidemiology of SARS-CoV-2 among influenza-like illness and severe Acute respiratory illness cases in selected health facilities in Ethiopia"],"prefix":"10.3389","volume":"13","author":[{"given":"Adamu","family":"Tayachew","sequence":"first","affiliation":[{"name":"Aklilu Lemma Institute of Pathobiology, Addis Ababa University","place":["Addis Ababa, Ethiopia"]},{"name":"Ethiopian Public Health Institute","place":["Addis Ababa, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawit Assefa","family":"Arimide","sequence":"additional","affiliation":[{"name":"Ethiopian Public Health Institute","place":["Addis Ababa, Ethiopia"]},{"name":"Translational Medicine, Clinical Virology, Lund University","place":["Malm\u00f6, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolde","family":"Shure","sequence":"additional","affiliation":[{"name":"Ethiopian Public Health Institute","place":["Addis Ababa, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejenie Shiferaw","family":"Teklu","sequence":"additional","affiliation":[{"name":"Ethiopian Public Health Institute","place":["Addis Ababa, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayele","family":"Gebeyehu","sequence":"additional","affiliation":[{"name":"Ethiopian Public Health Institute","place":["Addis Ababa, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsegaye","family":"Berkesa","sequence":"additional","affiliation":[{"name":"Ethiopian Public Health Institute","place":["Addis Ababa, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizaw","family":"Teka","sequence":"additional","affiliation":[{"name":"Ethiopian Public Health Institute","place":["Addis Ababa, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandefro","family":"Kebede","sequence":"additional","affiliation":[{"name":"Ethiopian Public Health Institute","place":["Addis Ababa, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesfin","family":"Wossen","sequence":"additional","affiliation":[{"name":"Ethiopian Public Health Institute","place":["Addis Ababa, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melkamu","family":"Abte","sequence":"additional","affiliation":[{"name":"Ethiopian Public Health Institute","place":["Addis Ababa, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesay","family":"Hailu","sequence":"additional","affiliation":[{"name":"Ethiopian Public Health Institute","place":["Addis Ababa, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelalem","family":"Mekuria","sequence":"additional","affiliation":[{"name":"Department of Veterinary Preventive Medicine, Ohio State University College of Veterinary Medicine","place":["Columbus, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nega","family":"Berhe","sequence":"additional","affiliation":[{"name":"Aklilu Lemma Institute of Pathobiology, Addis Ababa University","place":["Addis Ababa, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Medstrand","sequence":"additional","affiliation":[{"name":"Translational Medicine, Clinical Virology, Lund University","place":["Malm\u00f6, Sweden"]},{"name":"Science for Life Laboratory, Lund University","place":["Lund, Sweden"]},{"name":"Clinical Microbiology, Infection Control and Prevention, Laboratory Medicine","place":["Lund, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigatu","family":"Kebede","sequence":"additional","affiliation":[{"name":"Aklilu Lemma Institute of Pathobiology, Addis Ababa University","place":["Addis Ababa, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med."},{"key":"B2","unstructured":"WHO COVID-19 Dashboard\n          \n          2025"},{"key":"B3","unstructured":"COVID-19 Epidemiological Update- Special Edition\n          \n          2024"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1097\/JS9.0000000000000513","article-title":"The WHO declares COVID-19 is no longer a public health emergency of international concern: benefits, challenges, and necessary precautions to come back to normal life","volume":"109","author":"Sarker","year":"2023","journal-title":"Int J Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0132823","DOI":"10.1128\/spectrum.01328-23","article-title":"Integration of SARS-CoV-2 testing and genomic sequencing into influenza sentinel surveillance in Uganda, January to December 2022","volume":"11","author":"Kayiwa","year":"2023","journal-title":"Microbiol Spectr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2196\/50799","article-title":"Use of sentinel surveillance platforms for monitoring SARS-CoV-2 activity: evidence from analysis of kenya influenza sentinel surveillance data","volume":"10","author":"Owusu","year":"2024","journal-title":"JMIR Public Heal Surveill."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0294960","DOI":"10.1371\/journal.pone.0294960","article-title":"Epidemiology and burden of Severe Acute Respiratory Infections (SARI) in the aftermath of COVID-19 pandemic: a prospective sentinel surveillance study in a Tunisian Medical ICU, 2022\/2023","volume":"18","author":"Boussarsar","year":"2023","journal-title":"PLoS ONE"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0003093","DOI":"10.1371\/journal.pgph.0003093","article-title":"SARS-CoV-2 co-detection with influenza and human respiratory syncytial virus in Ethiopia: findings from the severe acute respiratory illness (SARI) and influenza-like illness (ILI) sentinel surveillance, January 01, 2021 to June 30, 2022","volume":"4","author":"Shure","year":"2024","journal-title":"PLOS Glob Public Heal"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lana.2022.100338","article-title":"Prevalence and predictors of anti-SARS-CoV-2 serology in a highly vulnerable population of Rio de Janeiro: a population-based serosurvey","volume":"15","author":"Coelho","year":"2022","journal-title":"Lancet Reg Heal - Am."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med [Internet]."},{"key":"B11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41579-022-00841-7","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat Rev Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijid.2021.08.028","article-title":"Seroprevalence and risk factors for SARS-CoV-2 Infection in selected urban areas in Ethiopia: a cross-sectional evaluation during July (2020)","volume":"111","author":"Tadesse","year":"2021","journal-title":"Int J Infect Dis [Internet]."},{"key":"B13","unstructured":"Coronavirus Resource Center\n          \n          2023"},{"key":"B14","unstructured":"All Influenza Data"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-024-47556-2","article-title":"Long-term monitoring of SARS-CoV-2 seroprevalence and variants in Ethiopia provides prediction for immunity and","volume":"15","author":"Merkt","year":"2024","journal-title":"Nat Commun."},{"key":"B16","unstructured":"End-to-End Integration of SARS-CoV-2 and Influenza Sentinel Surveillance\n          \n          2023"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/biomethods\/bpaa014","article-title":"Rapid and inexpensive whole-genome sequencing of SARS-CoV-2 using 1200 bp tiled amplicons and Oxford nanopore rapid barcoding","volume":"5","author":"Freed","year":"2021","journal-title":"Biol Methods Protoc."},{"key":"B18","unstructured":"1\n          54\n          PCR Tiling of SARS-CoV-2 Virus\n          \n          2021"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.21105\/joss.02906","article-title":"Augur: a bioinformatics toolkit for phylogenetic analyses of human pathogens","volume":"6","author":"Huddleston","year":"2021","journal-title":"J Open Source Softw"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1093\/nar\/gkf436","article-title":"MAFFT a novel method for rapid multiple sequence alignment based on fast Fourier transform","volume":"30","author":"Katoh","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","article-title":"IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era","volume":"37","author":"Minh","year":"2020","journal-title":"Mol Biol Evol."},{"key":"B22","unstructured":"8\n          9\n          \n            \n              Wantai\n              BioPharm\n            \n          \n          Wantai SARS-CoV-2 Diagnostics WANTAI SARS-CoV-2 Ab ELISA Diagnostic Kit for Total Antibody to SARS-CoV-2 (ELISA)\n          \n          2020"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1080\/22221751.2020.1835448","article-title":"Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)","volume":"9","author":"Meyer","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-17317-y","article-title":"An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment","volume":"11","author":"GeurtsvanKessel","year":"2020","journal-title":"Nat Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/5549893","article-title":"The escalating magnitude of COVID-19 infections among the Northeastern Ethiopia region: a community-based cross-sectional study","volume":"2021","author":"Geto","year":"2021","journal-title":"Int J Microbiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12931-025-03308-4","article-title":"Epidemiological characteristics of acute respiratory infectious diseases in the first year after COVID-19 pandemic in Guangdong Province, China","volume":"26","author":"Hu","year":"2025","journal-title":"Respir Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3855\/jidc.13698","article-title":"comparative analysis of COVID-19 outbreak on age groups and both the sexes of population from India and other countries","volume":"15","author":"Jakhmola","year":"2021","journal-title":"J Infect Dev Ctries."},{"key":"B28","doi-asserted-by":"publisher","first-page":"757459","DOI":"10.3389\/fmed.2021.757459","article-title":"Age-related risk factors and complications of patients with COVID-19: a population-based retrospective study","volume":"8","author":"Zhang","year":"2022","journal-title":"Front Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6061\/clinics\/2020\/e1912","article-title":"Susceptibility of the elderly to SARS-CoV-2 infection: ACE-2 overexpression, shedding, and antibody-dependent enhancement (ADE)","volume":"75","author":"Peron","year":"2020","journal-title":"Clinics."},{"key":"B30","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1186\/s12879-025-11330-6","article-title":"Epidemiology of respiratory syncytial virus and its subtypes among cases of influenza like illness and severe acute respiratory infection : findings from nationwide sentinel surveillance in Ethiopia","volume":"25","author":"Tayachew","year":"2025","journal-title":"BMC Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-020-0962-9","article-title":"Age-dependent effects in the transmission and control of COVID-19 epidemics","volume":"26","author":"Davies","year":"2020","journal-title":"Nat Med."},{"key":"B32","unstructured":"2022\n          2032\n          Global Genomic Surveillance Strategy for Pathogens With Pandemic and Epidemic Potential\n          \n          2022"},{"key":"B33","unstructured":"Tracking SARS-CoV-2 Variants\n          \n          2025"},{"key":"B34","first-page":"1","volume-title":"SARS-CoV-2 Genomic Sequencing for Public Health Goals-Nterim Guidance","year":"2021"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e29694","DOI":"10.1016\/j.heliyon.2024.e29694","article-title":"Characterize and analysis of meteorological and hydrological drought trends under future climate change conditions in South Wollo, North Wollo, and Oromia Zones, in Ethiopia","volume":"10","author":"Alemu","year":"2024","journal-title":"Heliyon."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1498203","DOI":"10.3389\/fepid.2024.1498203","article-title":"Trends, seasonal variations and forecasting of chronic respiratory disease morbidity in charcoal producing areas, northwest Ethiopia: time series analysis","volume":"4","author":"Tesfa","year":"2024","journal-title":"Front Epidemiol."},{"key":"B37","unstructured":"Trends in COVID-19 Cases, African Region\n          \n          2025"},{"key":"B38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12879-023-08168-1","article-title":"Spread and seasonality of COVID-19 pandemic confirmed cases in sub-Saharan Africa: experience from Democratic Republic of Congo, Nigeria, Senegal, and Uganda","volume":"23","author":"Adebowale","year":"2023","journal-title":"BMC Infect Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"8728","DOI":"10.1038\/s41467-024-53033-7","article-title":"Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1186\/s12879-025-11107-x","article-title":"Genome diversity of SARS-CoV-2 lineages associated with vaccination breakthrough infections in Addis Ababa, Ethiopia","volume":"25","author":"Aga","year":"2025","journal-title":"BMC Infect Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"938","DOI":"10.15585\/mmwr.mm7342a1","article-title":"Genomic surveillance for SARS-CoV-2 variants: circulation of omicron XBB and JN","volume":"73","author":"Ma","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1484637","DOI":"10.3389\/fcimb.2024.1484637","article-title":"Genomic epidemiology and evolutionary dynamics of the Omicron variant of SARS-CoV-2 during the fifth wave of COVID-19 in Pakistan","volume":"14","author":"Razzaq","year":"2024","journal-title":"Front Cell Infect Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/acmi.0.000853.v4","article-title":"Genetic diversity and genomic epidemiology of SARS-CoV-2 during the first 3 years of the pandemic in Morocco: comprehensive sequence analysis, including the unique lineage B1528 in Morocco","volume":"6","author":"Djorw\u00e9","year":"2024","journal-title":"Access Microbiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/S1473-3099(23)00744-2","article-title":"Fast evolution of SARS-CoV-2 BA286 to JN1 under heavy immune pressure","volume":"24","author":"Yang","year":"2024","journal-title":"Lancet Infect Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v17010064","article-title":"Two years of SARS-CoV-2 omicron genomic evolution in Brazil (2022\u20132024): subvariant tracking and assessment of regional sequencing efforts","volume":"17","author":"Souza UJB","year":"2025","journal-title":"Viruses."},{"key":"B46","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12985-024-02443-6","article-title":"Detection and comparison of SARS-CoV-2 antibody produced in naturally infected patients and vaccinated individuals in Addis Ababa, Ethiopia: multicenter cross-sectional study","volume":"21","author":"Bashea","year":"2024","journal-title":"Virol J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 MONTHS","volume":"385","author":"Levin","year":"2021","journal-title":"N Engl J Med."},{"key":"B48","unstructured":"Statement on the Fifteenth Meeting of the International Health Regulations 2005 Emergency Committee Regarding the Coronavirus Disease (COVID-19) Pandemic"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1714899\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T07:09:28Z","timestamp":1769411368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1714899\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":48,"alternative-id":["10.3389\/fpubh.2025.1714899"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1714899","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"article-number":"1714899"}}